Marcell Csanádi

1.4k total citations
70 papers, 654 citations indexed

About

Marcell Csanádi is a scholar working on Economics and Econometrics, Oncology and General Health Professions. According to data from OpenAlex, Marcell Csanádi has authored 70 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Economics and Econometrics, 20 papers in Oncology and 15 papers in General Health Professions. Recurrent topics in Marcell Csanádi's work include Pharmaceutical Economics and Policy (27 papers), Health Systems, Economic Evaluations, Quality of Life (26 papers) and Colorectal Cancer Screening and Detection (11 papers). Marcell Csanádi is often cited by papers focused on Pharmaceutical Economics and Policy (27 papers), Health Systems, Economic Evaluations, Quality of Life (26 papers) and Colorectal Cancer Screening and Detection (11 papers). Marcell Csanádi collaborates with scholars based in Hungary, Netherlands and United Kingdom. Marcell Csanádi's co-authors include Zoltán Kaló, Piotr Ozierański, András Inotai, János G. Pitter, Harry J. de Koning, Mirjana Huić, Martin McKee, Shai Mulinari, Adrian Gheorghe and Finn Børlum Kristensen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and BMC Public Health.

In The Last Decade

Marcell Csanádi

61 papers receiving 643 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcell Csanádi Hungary 14 343 161 106 100 72 70 654
Jaime Espín Spain 17 411 1.2× 101 0.6× 112 1.1× 66 0.7× 44 0.6× 69 794
James D. Chambers United States 22 671 2.0× 118 0.7× 205 1.9× 109 1.1× 85 1.2× 90 1.2k
M Franken Netherlands 18 271 0.8× 244 1.5× 103 1.0× 48 0.5× 20 0.3× 53 690
Eva Karlsson Sweden 15 242 0.7× 440 2.7× 101 1.0× 36 0.4× 74 1.0× 30 1.1k
Andrae Vandross United States 7 227 0.7× 103 0.6× 108 1.0× 31 0.3× 25 0.3× 19 547
Fabrice Smieliauskas United States 13 225 0.7× 120 0.7× 80 0.8× 34 0.3× 14 0.2× 28 640
Renee L. Gennarelli United States 12 128 0.4× 496 3.1× 111 1.0× 113 1.1× 113 1.6× 34 953
Julia R. Trosman United States 19 282 0.8× 230 1.4× 107 1.0× 20 0.2× 39 0.5× 91 868
Jan Geißler United Kingdom 12 185 0.5× 110 0.7× 219 2.1× 16 0.2× 71 1.0× 48 786
Yuki Shimada Japan 15 159 0.5× 126 0.8× 54 0.5× 79 0.8× 184 2.6× 66 714

Countries citing papers authored by Marcell Csanádi

Since Specialization
Citations

This map shows the geographic impact of Marcell Csanádi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcell Csanádi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcell Csanádi more than expected).

Fields of papers citing papers by Marcell Csanádi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcell Csanádi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcell Csanádi. The network helps show where Marcell Csanádi may publish in the future.

Co-authorship network of co-authors of Marcell Csanádi

This figure shows the co-authorship network connecting the top 25 collaborators of Marcell Csanádi. A scholar is included among the top collaborators of Marcell Csanádi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcell Csanádi. Marcell Csanádi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Németh, Bertalan, et al.. (2025). Economic evaluations and health economic models of soft tissue sarcomas: Systematic literature review from a European and North American perspective. Critical Reviews in Oncology/Hematology. 209. 104661–104661.
2.
3.
Csanádi, Marcell, et al.. (2025). Implementing health economics for pharmacogenomics research translation in Africa. Communications Medicine. 5(1). 241–241.
4.
Lorenzovici, László, Andrea Ildikó Gáspárik, Carsten Utoft Niemann, et al.. (2023). Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia. BioDrugs. 37(2). 219–233. 3 indexed citations
5.
Hegedűs, Tamás, et al.. (2023). Goals and methods of managed entry agreements – can we get what we want?. Health Policy and Technology. 12(2). 100745–100745. 3 indexed citations
6.
Zielonke, N., Carlo Senore, Antonio Ponti, et al.. (2023). Overcoming barriers: Modelling the effect of potential future changes of organized breast cancer screening in Italy. Journal of Medical Screening. 30(3). 134–141. 1 indexed citations
7.
Lorenzovici, László, et al.. (2022). Burden of Chronic Heart Failure in Romania. Healthcare. 10(1). 107–107. 10 indexed citations
8.
Csanádi, Marcell, Zoltán Kaló, Maureen Rutten‐van Mölken, et al.. (2022). Prioritization of implementation barriers related to integrated care models in Central and Eastern European countries. Health Policy. 126(11). 1173–1179. 12 indexed citations
9.
Gini, Andrea, Nicolien T. van Ravesteyn, Erik E. L. Jansen, et al.. (2021). The EU-TOPIA evaluation tool: An online modelling-based tool for informing breast, cervical, and colorectal cancer screening decisions in Europe. Preventive Medicine Reports. 22. 101392–101392. 10 indexed citations
10.
Ozierański, Piotr, et al.. (2021). A ‘patient–industry complex’? Investigating the financial dependency of UK patient organisations on drug company funding. Sociology of Health & Illness. 44(1). 188–210. 11 indexed citations
11.
Csanádi, Marcell, et al.. (2020). Patient-reported symptom burden of chronic graft versus host disease: a systematic literature review. Expert Review of Hematology. 13(10). 1119–1130. 3 indexed citations
12.
Ozierański, Piotr, et al.. (2020). Underreporting of drug industry payments to patient organisations in the UK (2012-2016). Pure (University of Bath). 1 indexed citations
13.
Ágh, Tamás, Marcell Csanádi, Zoltán Vokó, et al.. (2019). Humanistic burden of patients with chronic graft-versus-host disease - systematic literature review of health-related quality of life and functional status. Expert Review of Hematology. 12(5). 295–309. 11 indexed citations
14.
Csanádi, Marcell, Eveline A.M. Heijnsdijk, Ahti Anttila, et al.. (2019). Key indicators of organized cancer screening programs: Results from a Delphi study. Journal of Medical Screening. 26(3). 120–126. 11 indexed citations
15.
Harsányi, András, et al.. (2019). Influence of biosimilar infliximab launch on the utilization pattern of biological medicines: the case of Hungary. Expert Review of Pharmacoeconomics & Outcomes Research. 20(6). 653–659. 6 indexed citations
16.
Kaló, Zoltán, et al.. (2019). Is there a fair allocation of healthcare research funds by the European Union?. PLoS ONE. 14(4). e0207046–e0207046. 11 indexed citations
17.
Löblová, Olga, Marcell Csanádi, Piotr Ozierański, et al.. (2019). Alternative access schemes for pharmaceuticals in Europe: Towards an emerging typology. Health Policy. 123(7). 630–634. 12 indexed citations
18.
Csanádi, Marcell, Tamás Ágh, Attila Tordai, et al.. (2019). A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host disease. Expert Review of Hematology. 12(5). 311–323. 18 indexed citations
19.
Csanádi, Marcell, Piotr Ozierański, Olga Löblová, et al.. (2019). Shedding light on the HTA consultancy market: Insights from Poland. Health Policy. 123(12). 1237–1243. 4 indexed citations
20.
Csanádi, Marcell, Zoltán Kaló, Leoš Fuksa, et al.. (2018). The implications of external price referencing on pharmaceutical list prices in Europe. Health Policy and Technology. 7(3). 243–250. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jaime Espín Breakdown of academic impact, for papers by James D. Chambers Breakdown of academic impact, for papers by M Franken Breakdown of academic impact, for papers by Eva Karlsson Breakdown of academic impact, for papers by Andrae Vandross Breakdown of academic impact, for papers by Fabrice Smieliauskas Breakdown of academic impact, for papers by Renee L. Gennarelli Breakdown of academic impact, for papers by Julia R. Trosman Breakdown of academic impact, for papers by Jan Geißler Breakdown of academic impact, for papers by Yuki Shimada
Rankless by CCL
2026